Topic: Anxiety

« Back

Print this page

	Personalized Program The Personalized Program enables you to compile an individual program with events and contributions of your interest. Therefore, it can be used very well to plan your actual congress visit at an early point of time. Please log in to use the Personalized Program.	» Login » Identification » Help

	Sunday, 28. June 2009	next day »

No.	S-09 - Symposium
Time:	11.00-12.30
Room:	Room 352AB
Topic:	Anxiety
Track:	1 Basic
Session title:	Glutamate as a neurobiological target in anxiety disorders: Metabotropic or ionotropic receptors?
	Brian Harvey, South Africa	Chair
	Mohammed Shahid, United Kingdom	Co-Chair

001	Role of the glutamate system in the neurobiology of anxiety and stress related disorders: How strong is the therapeutic rationale?
	S.J. Mathew, USA	Speaker
002	Role of animal models in the development of current and novel therapeutic strategies for anxiety disorders
	John Cryan, Ireland	Speaker
003	Targeting metabotropic glutamate receptors: Evidence to support pharmacological validation in anxiety and stress disorders
	Andrzej Pilc, Poland	Speaker
004	Targeting ionotropic glutamate receptors: Therapeutic rationale in anxiety and stress disorders
	Wojciech Danysz, Germany	Speaker

No.	P-03 - Poster Presentation
Time:	12.30-14.00
Room:	Foyer
Topic:	Anxiety
Session title:	Anxiety I
	Sabine Herpertz, Germany	Chair

001	Sustained attention on Bosnian war veterans with PTSD diagnosis
	Aida Sarac-Hadzihalilovic, Bosnia and Herzegovina	Presenter
002	Salivary cortisol and emotional arousal in Bosnian refugees with PTSD
	Aida Spahic-Mihajlovic, USA	Presenter
003	Application of ASEX-scale for patients with posttraumatic stress disorder by telepsychiatry and psychiatry
	Milan Stojakovic, Bosnia and Herzegovina	Presenter
004	The model of prediction of neurotic, stress-related and somatoform disorders
	Lyudmila Ryadovaya, Russia	Presenter
005	Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with Generalised Anxiety Disorder (GAD)
	Kairi Mägi, Estonia	Presenter
006	Pharmacology of neuropeptides in a mouse model of extremes in anxiety-related behavior
	Yi-Chun Yen, Germany	Presenter
007	Improvement of cognitive functions in anxiety patients treated with psychotherapy and pharmacotherapy
	Krzysztof Krysta, Poland	Presenter
008	Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy for the acute treatment of patients with Generalised Anxiety Disorder (GAD): An analysis of pooled data
	Borwin Bandelow, Germany	Presenter
009	Frequency and clinical correlates of adult separation anxiety disorder in a sample of 508 outpatients with mood and anxiety disorders
	Marianna Abelli, Italy	Presenter
010	Morphological analyses of neurons in serotonin transporter knockout mice
	Sarah Louise Nietzer, Germany	Presenter
011	Efficacy of alprazolam sub-lingual tablets in the acute phase of panic disorders
	Miguel Márquez, Argentina	Presenter
012	Executive and metacognitive deficit in the social anxiety disorders
	Miguel Márquez, Argentina	Presenter
013	Generalized anxiety disorder: The neuropsychological approach
	Miguel Márquez, Argentina	Presenter
014	Increased anxiety-like behaviours and impaired anxiolytic response to benzodiazepines in prodynorphin knock out mice is assoctiated to alterations in Gaba a receptor subunits gene expression and MAPK signaling pathway
	Jorge Manzanares, Spain	Presenter
015	Subtypes not respiratory of panic disorders and their correlation with fear of physical activity
	Ricardo Muotri, Brazil	Presenter
016	Quetiapine monotherapy in the treatment of posttraumatic stress disorder: A randomized, controlled trial
	Mark Hamner, USA	Presenter
017	Agoraphobia-leading women syndrom
	Tatijana Kozarov, Serbia and Montenegro	Presenter
018	Posttraumatic Stress Disorder (PTSD) and psychotic symptoms
	Narcisa Pojskic, Bosnia and Herzegovina	Presenter
019	Korean medication algorithm project for generalized anxiety disorder 2009: Initial treatment strategies
	Min-Sook Kim, Korea, Republic of	Presenter
020	Proinflammatory cytokine and HPA-axis responses to the combined dex/CRH test in remitted subjects with posttraumatic stress disorder and trauma controls
	Nicole Szesny, Germany	Presenter

No.	S-17 - Symposium
Time:	14.00-15.30
Room:	Room 241
Topic:	Anxiety
Track:	3 Interface
Session title:	Translational neuroscience may inform treatment development for posttraumatic stress disorder
	Leo Sher, USA	Chair
	Alexander Neumeister, USA	Co-Chair

001	Early postnatal stress: Impact on neural circuits and relevance to psychophysiology
	Machiko Matsumoto, Japan	Speaker
002	Long term alterations in brain and neurobiology in PTSD
	Eric Vermetten, Netherlands	Speaker
003	Mechanisms of resilience: Lessons from PET imaging
	Alexander Neumeister, USA	Speaker
004	Neurobiology of suicidal behavior in PTSD and implications for suicide prevention
	Leo Sher, USA	Speaker

No.	S-25 - Symposium
Time:	16.00-17.30
Room:	Room 251
Topic:	Anxiety
Track:	3 Interface
Session title:	Peripheral and central mechanisms involved in post-traumatic stress disorder and its treatment
	Stephanie Khalfa, France	Chair
	Tanja Michael, Switzerland	Co-Chair

001	Translational research in the neuroscience of fear extinction: Implications to PTSD and other anxiety disorders
	Mohammed R. Milad, USA	Speaker
002	Variability of symptoms in daily life of patients with PTSD
	Tanja Michael, Switzerland	Speaker
003	Update on biopsychological correlates and predispositions of PTSD and its successful CBT treatment
	Anke Karl, United Kingdom	Speaker
004	Fear conditioning/extinction in PTSD before and after treatment
	Stephanie Khalfa, France	Speaker

« previous day	Monday, 29. June 2009	next day »

No.	FC-08 - Free Communications
Time:	08.00-09.30
Room:	Room 242A
Topic:	Anxiety
Session title:	Anxiety I
	Alexander Neumeister, USA	Chair
	Brian Harvey, South Africa	Co-Chair

001	Neural and physiological phenotypes in zebrafish models of stress
	Allan Kalueff, USA	Speaker
002	PTSD symptom severity and co-morbid psychiatric disorders
	Usha Barahmand, Iran	Speaker
003	Balneotherapy in the treatment of generalized anxiety disorder
	Olivier Dubois, France	Speaker
004	Interleukin-18 initiates goblet cell-dependent mucosal barrier dysfunction of the mouse rectum in response to psychosocial stress
	Kensei Nishida, Japan	Speaker
005	Effects of the dorsal hippocampal opioidergic system in the modulation of anxiety
	Jalal Solati, Iran	Speaker

No.	S-40 - Symposium
Time:	16.00-17.30
Room:	Room 252B
Topic:	Anxiety
Track:	3 Interface
Session title:	New insight into panic disorder
	Eduard Maron, Estonia	Chair
	David Nutt, United Kingdom	Co-Chair

001	Perspectives in research and treatment of panic disorder
	David Nutt, United Kingdom	Speaker
002	Challenge tests
	Jakov Shlik, Canada	Speaker
003	Genetics of panic disorder: New evidences
	Francis McMahon, USA	Speaker
004	Neuroimaging of panic disorder
	Eduard Maron, Estonia	Speaker

« previous day	Tuesday, 30. June 2009	next day »

No.	S-53 - Symposium
Time:	11.00-12.30
Room:	Room 251
Topic:	Anxiety
Track:	1 Basic
Session title:	Neurobiological correlates of dissociation and influence on information processing in stress-related disorders
	Eric Vermetten, Netherlands	Chair
	Petra Ludäscher, Germany	Co-Chair

001	Neural correlates of dissociation in patients with posttraumatic stress disorder
	Eric Vermetten, Netherlands	Speaker
002	The neural correlates of emotional distraction during working memory performance in traumatized patients with borderline personality disorder
	Annegret Krause, Germany	Speaker
003	Influence of dissociation on information processing in stress-related disorders
	Jana Mauchnik, Germany	Speaker
004	Neural correlates of dissociation in patients with borderline personality disorder
	Ruth Lanius, Canada	Speaker

No.	FC-18 - Free Communications
Time:	12.30-14.00
Room:	Room 351
Topic:	Anxiety
Session title:	Anxiety II
	Veronica Larach-Walters, Chile	Chair
	Martijn Figee, Netherlands	Co-Chair

001	Transgenerational transmission of trauma - case of Albania
	Ariel Como, Albania	Speaker
002	Reduced resting state connectivity between amygdala and orbitofrontal cortex in social phobia
	Patrycja Stein, Austria	Speaker
003	Examining changes in resistant anxiety symptoms of ADHD with co-morbid generalized anxiety disorder in adult patients treated with mixed amphetamine salts (adderall XR)
	Adel Gabriel, Canada	Speaker
004	GSK3ß as a biological marker of stress in the prefrontal cortex
	Julie Bourgin, France	Speaker
005	Personality and clinical correlates of response to a laboratory stressor in patients with social anxiety disorder
	Diana Koszycki, Canada	Speaker
006	Long term consequences on mental health of traumatic exposure in an elderly general population and impact of genetic vulnerability
	Isabelle Chaudieu, France	Speaker

No.	P-23 - Poster Presentation
Time:	12.30-14.00
Room:	Foyer
Topic:	Anxiety
Session title:	Anxiety II
	Gerardo M. Heinze, Mexico	Chair

001	Is there a Metabolic Syndrome in PTSD: Lipid level alterations in veterans with chronic PTSD
	Alma Dzubur Kulenovic, Bosnia and Herzegovina	Presenter
002	Safety and efficacy of Venlafaxine in the treatment of depressive disorder comorbid with generalized anxiety disorder
	Alma Dzubur Kulenovic, Bosnia and Herzegovina	Presenter
003	A controlled trial of Eye Movement Desensitisation and Reprocessing (EMDR) treatment for phobia
	Antoine Pelissolo, France	Presenter
004	Initial CAPS measurement after psychic trauma strongly correlates with changes of hippocampal volume after one and after six months
	Dino Santangelo de Souza, Germany	Presenter
005	Lymphocyte glucocorticoid receptor expression and functional properties in Balkan war veterans with and without PTSD
	Gordana Matic, Serbia and Montenegro	Presenter
006	Pharmacotherapy of the complex Posttraumatic Stress Disorder
	Grozdanko Grbesa, Serbia and Montenegro	Presenter
008	Glucocorticoid receptor mRNA level in war veterans with and without PTSD
	Jelena Brkljacic, Serbia and Montenegro	Presenter
009	Complement system as a key component of immune respone associated with posttraumatic stress disorder
	Lilit Hovhannisyan, Armenia	Presenter
010	A quality of life in chronic combat related Posttraumatic Stress Disorder (PTSD): A study on Croatian war veterans
	Marijana Bras, Croatia	Presenter
011	The connection between coping mechanisms, depression, anxiety and fatigue in multiple sclerosis
	Marijana Bras, Croatia	Presenter
012	The investigating of the effectiveness of biofeedback (galvanic skin response) on war veterans with PTSD
	Mehdi Sahragard Toghchi, Iran	Presenter
013	The investigating of the effectiveness of eye movement desensitization and reprocessing on war veterans with PTSD
	Mehdi Sahragard Toghchi, Iran	Presenter
014	Posttraumatic stress disorder (PTSD): The impact of changes in diagnostic criteria
	Michael Van Ameringen, Canada	Presenter
015	Childhood maltreatment accociated with greater symptom secerity and poorer quality of life and function in social anxiety disorder
	Michael Van Ameringen, Canada	Presenter
016	The behavioral and neurochemical Ladasten effects depend on emotional stress reaction responses
	Mikhail Voronin, Russia	Presenter
017	Plasma serotonin level of Vietnam War veterans with posttraumatic stress disorder after long-term drug treatment
	Moon-Y. Chung, Korea, Republic of	Presenter
018	Dynamics of biological age dimensions after exposure to extreme situations
	Svetlana Tsaregorodtseva, Russia	Presenter
019	Caffeine challenge and breath-holding duration in patients with panic disorder
	Vasilios Masdrakis, Greece	Presenter
020	Efficacy of sertindole and combination of flufenazine and one SSRI (fluoxetine or fluvoxamine) in treatment of PTSD patients with psychotic symptoms
	Vladimir Grosic, Croatia	Presenter
021	Preliminary data on the French version of the Hypomania Checklist (HCL-32)
	E. Hantouche, France	Presenter

« previous day	Wednesday, 1. July 2009	next day »

No.	S-60 - Symposium
Time:	08.00-09.30
Room:	Blue Amphitheatre
Topic:	Anxiety
Track:	2 Clinical
Session title:	Disaster follow-up: International perspectives
	Joseph Zohar, Israel	Chair
	Manickam Thirunavukarasu, India	Co-Chair

001	9/11 – American insights
	Rachel Yehuda, USA	Speaker
002	1999 earthquake in Turkey – the lessons from a seven year follow-up
	Oguz Karamustafalioglu, Turkey	Speaker
003	Tsunami 2004 - retrospective introspection
	Manickam Thirunavukarasu, India	Speaker
004	Can PTSD be prevented?
	Joseph Zohar, Israel	Speaker

No.	S-68 - Symposium
Time:	11.00-12.30
Room:	Room 352AB
Topic:	Anxiety
Track:	1 Basic
Session title:	The cortical-striatal network in obsessive-compulsive disorder and depression
	Martijn Figee, Netherlands	Chair
	Donald Malone, USA	Co-Chair

001	Limbic-prefrontal control is improved in paroxetine responders, but the ventral striatum is also involved in SSRI-response
	H.G. Ruhe, Netherlands	Speaker
002	The effects of ventral capsule/ventral striatum stimulation in depression
	Donald Malone, USA	Speaker
003	Imaging neurotransmission in the cortical-striatal network of OCD
	Martijn Figee, Netherlands	Speaker
004	Disinhibition of frontal-striatal circuits in the compulsive-impulsive spectrum
	Odile A. van den Heuvel, Netherlands	Speaker

No.	P-34 - Poster Presentation
Time:	12.30-14.00
Room:	Foyer
Topic:	Anxiety
Session title:	Anxiety III
	Mathias Berger, Germany	Chair

001	Ex-service men and psychotraumatism in Algeria
	Benabbas Malik, Algeria	Presenter
002	Combination of pharmacotherapy and psychotherapy in the treatment of patients with panic disorder
	Dusan Kolar, Serbia and Montenegro	Presenter
003	HPA-axis behavior is correlated with personality
	Danka Savic, Serbia and Montenegro	Presenter
004	Predictors of clinical response to placebo in patients with anciety disorder
	Roxana Galeno, Argentina	Presenter
005	Cannabinoid receptor ligands suppress anxiety-related effects of d-amphetamine and nicotine in the elevated plus maze test in mice
	Grazyna Biala, Poland	Presenter
006	Parental anxiety and quality of life in children with blindness in Ababasire institution
	Homayoon Naji, Iran	Presenter
007	Relationship between Hepatocyte growth factor and anxiety and depression
	Jotaro Akiyoshi, Japan	Presenter
008	The reletionship between depersonalization, derealization and number of traumatic events during childhood and adolescence in healthy individuals
	Katarina Adamcova, Czech Republic	Presenter
009	Mental fatigue after brain injury and the supporting systems of the brain
	Lars Rönnbäck, Sweden	Presenter
010	Anxiolytic efficacy and time to onset of pregabalin in patients with Generalized Anxiety Disorder: Open label, non-comparative, flexible-dose study
	Matthias Brasser, Germany	Presenter
011	Pregabalin treatment for Generalized Anxiety Disorder under clinical practice conditions: Global response as assessed by patients and physicians
	Matthias Brasser, Germany	Presenter
012	Efficacy of ECT in chronic, severe, antidepressant - and CBT refractory posttraumatic stress disorder: An open, prospective study
	Mushtaq Margoob, India	Presenter
013	Cognitive mechanisms involved in PTSD and its treatment
	Myriam El-Khoury, France	Presenter
014	Differential rearing condition interferes with caffeine’s effect in the adult rats
	Noppamars Wongwitdecha, Thailand	Presenter
015	Effect of barakol on the elevated plus-maze behavior of social and isolation reared rats
	Noppamars Wongwitdecha, Thailand	Presenter
016	Stress during brain development reduces the anti-aggressive effect of clonidine
	Noppamars Wongwitdecha, Thailand	Presenter
017	Diagnostics and rehabilitation of patients with posttraumatic stressful frustration
	Oleg Panchenko, Ukraine	Presenter
018	Syndrome of medical posttraumatic stressful dezoder at children of preschool and early school age
	Oleg Panchenko, Ukraine	Presenter
019	Parity of biological and psychological age in psychiatric practice
	Oleg Panchenko, Ukraine	Presenter
020	Posttraumatic Stress Disorder: predictors factors
	Policarpo Rebolledo, Chile	Presenter

« previous day	Thursday, 2. July 2009

No.	TG-09 - WFSBP Treatment Guidelines
Time:	11.00-12.30
Room:	Room 242A
Topic:	Anxiety
Session title:	Anxiety
	Robertas Bunevicius, Lithuania	Chair

	Joseph Zohar, Israel	Presenter
	Veronica Larach-Walters, Chile	Presenter

No.	S-88 - Symposium
Time:	14.00-15.30
Room:	Room 352AB
Topic:	Anxiety
Track:	1 Basic
Session title:	Recent advances in neuropharmacology of stress
	Noppamars Wongwitdecha, Thailand	Chair
	Mitsuhiro Yoshioka, Japan	Co-Chair

001	Early life stress modifies the effects of 5-HT1A agonist, 8-OH-DPAT in animal tests of anxiety and depression
	Noppamars Wongwitdecha, Thailand	Speaker
002	Early postnatal stress disturbs normal development of the serotonergic neurons in the raphe nuclei
	Mitsuhiro Yoshioka, Japan	Speaker
003	Pros and cons of stress on the development of social behavior
	Shun Nakamura, Japan	Speaker
004	Behavior recognition technology application in neuropharmacology of stress
	Yiqing Liang, USA	Speaker

« Back

---